Page 1 of 7
- Toll Free: +1-800-792-5285
- (UK): +44-845-528-1300
- Int'l: +1-503-894-6022
- Help@alliedmarketresearch.com
Cart
Global pharmaceutical industry completely relies on research and development to expand its offerings among consumers. Continuous development of drug compounds, discovery of new ones, and establishment of most effective routes for drug delivery after intensive clinical trials are crucial. Allied Market Research presents a compilation of reports, which offers a quantitative analysis of growth indicative figures, and extensively define each sub-segment of the market. These furnish our clients an insider’s approach to the industry, and assist stakeholders in forming investment strategies.
Page 1 of 7
The global cognitive and memory enhancer drugs market was valued at $3,680 million in 2016, and is projected to reach $6,598 million by 2023, growing at a CAGR of 8.6% from 2017 to 2023. Cognitive enhancers are drugs and supplements, ...
Genes are composed of DNA that contains necessary information for making proteins that are vital for the human body to function optimally. Some gene mutations result in these proteins not being made correctly and can lead to genetic disorders. Gene ...
Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every ...
The India IVF Services Market was valued at $256.0 million in 2016, and is estimated to reach $829.5 million by 2023, registering a CAGR of 18.2% from 2017-2023. The India IVF services market is developing steadily and is projected to ...
In Vitro Fertilization (IVF) Services Market generated a revenue of $9,876 million in 2016 and is expected to reach $19.676 million by 2023, at a CAGR of 10.5% from 2017 to 2023. In vitro fertilization is the process of artificial ...
Gynecological Cancer Drugs Market size was valued at $9,269 million in 2016, and is expected to reach $16,107 million by 2023, growing at a CAGR of 8.1% from 2017 to 2023.
3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, as a result of ...
The global cephalosporin market was valued at $77,764 million in 2016, and is estimated to reach $1,99,754 million by 2023, growing at a CAGR of 14.4% from 2017 to 2023. Cephalosporin is a bactericidal β-lactam antibiotic, which is used to ...
The Global Gastroparesis Market was valued at $4,667 million in 2016, and is projected to reach $6,486 million at a CAGR of 4.7% from 2017 to 2023. Gastroparesis is a medical condition of the stomach, which affects the normal spontaneous ...
Global Ophthalmic Drugs Market size was valued at $29,613 million in 2016, and is expected to reach $42,663 million by 2023, registering a CAGR of 5.3% from 2017 to 2023. Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic ...
Global Protein Therapeutics Market accounted for $140,109 million in 2016, and is anticipated to reach $217,591 million by 2023, registering a CAGR of 6.5% from 2017 to 2023. Therapeutic protein drugs are an important class of medicines, which are administered ...
The Global Pain Management Drugs Market is estimated to reach from $58,577 million in 2016, $77,131 million by 2023. It is anticipated to register a CAGR of 4% during the forecast period, 2017-2023. Pain is a distressing sensory and emotional ...
The global BCG vaccine market was valued at $20,366 thousands in 2016, and is estimated to reach $28,051 thousands by 2023, growing at a CAGR of 4.6% from 2017 to 2023. Bacillus Calmette“Guérin (BCG) vaccine is the only vaccine currently ...
Ulcerative Colitis (UC) is a chronic, debilitating disease that affects large intestine or colon. The cause of ulcerative colitis is unknown however, researchers believe that it is an exaggerated immune response to a microbial trigger. UC is characterized by inflammation ...
Antibody Drug Conjugates Market are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. ADC™s are designed to eliminate cancer cells only without harming the normal cells. This is a major advantage of ADC™s as the unharmed ...
The global diabetes therapeutics market was valued at $66,993 million in 2016, and is estimated to reach $186,842 million by 2023, growing at a CAGR of 16.0% from 2017 to 2023. Diabetes therapeutics are drugs used by diabetics to maintain the blood glucose levels to restore the blood glucose metabolism to a normal state.
global over the counter (OTC) drugs & dietary supplements market was valued at $223 billion in 2016, and is expected to reach $335 billion by 2023, registering a CAGR of 5.9% from 2017 to 2023. OTC drugs are also known ...
global nanomedicine market accounted for $111,912 million in 2016, and is anticipated to reach $261,063 million by 2023, registering a CAGR of 12.6% from 2017 to 2023. Nanomedicine is one of the applications of nanotechnology used in diagnosis, treatment, monitoring, ...
global immunoglobulin was valued at $8,374 million in 2016, and is projected to reach $13,619 million by 2023, registering a CAGR of 7.3% from 2017 to 2023. Immunoglobulin is a protein produced by plasma cells and other lymphocytes. They are ...
Global Cancer Vaccines Market is expected to reach at $12,814 million from $4,073 million and register a CAGR of 17.7%, during the forecast period, 2017 - 2023.
Global Antifungal Drugs Market is expected to rise from $13,719 million in 2016 to $17,718 million by 2023. The industry is anticipated to register a CAGR of 3.7%, during the forecast period, 2017“ 2023. The antifungal drugs detect and eliminate ...
Global Potential Analysis of Human DNA Vaccines Market is expected to account for $3,762 million in 2020 and reach $9,337 million by 2030, by growing at a CAGR of 9.5% during the period, 2020 - 2030.
Malaysia IVIG Market is estimated to reach at $18,649 million from $12,277 thousand and register a CAGR of 6.1% during the period, 2016“ 2022. IVIG is a blood derived product formulated from the serum of between ~10, 000 donors per ...
Global Vaccines Market was valued at $31,216 million in 2016, and is expected to reach $65,148 million in 2023, and register a CAGR of 10.9%, during the forecast period, 2017“ 2023. Vaccine is a biological preparation that is administered to ...
Global Orphan Drugs Market is expected to garner $169 billion from $106 billion and register a CAGR of 6.8% during the forecast period, 2016“2022. Orphan drug can be defined as a pharmaceutical agent specifically designed to treat rare (orphaned) diseases. ...
Global Animal Vaccines Market is expected to garner $9,159 million, registering a CAGR of 5.2% during the forecast period, 2016-2022. Animal vaccines control the transmission diseases, thus providing protection to animal and human health. Animals serve as an important source ...
Global Male Hypogonadism Market is estimated to reach $3,233 million from $2,594 million and is supported by a CAGR of 3.1% during the forecast period. Male hypogonadism is a medical condition in which testes cannot produce enough testosterone, resulting in ...
Global HIV Drug Market was valued at $20,448 million in 2015 and is expected to garner $26,458 million by 2022, registering a CAGR of 3.7% during the forecast period 2016-2022. Human immunodeficiency virus (HIV) is one of the most infectious ...
The global chemotherapy-induced Nausea and Vomiting (CINV) market was valued at $1,663 million in 2015, and is estimated to reach $2,659 million by 2022, registering a CAGR of 7.1% during the forecast period 2016-2022. Nausea and vomiting (emesis) caused by cancer ...
The global phytosterols market size is expected to reach $935 million by 2022 from $490 million in 2015 at a CAGR of 9.62% from 2016 to 2022. The phytosterols market holds substantial scope for growth globally. Its contribution to the ...
The Zika virus vaccines market is estimated to reach $18,697 million by 2022 from $14,500 million in 2017. The Zika virus vaccines market growth rate is 5.2% during the forecast period. Zika virus infection is a mosquito-borne illness transmitted through Aedes genus same as other mosquito-borne illness such as japanese encephalitis virus, West Nile viruses, and yellow fever virus.
The global netupitant“palonosetron FDC market accounted for $257,162 million in 2015, and is estimated to reach $527,187 million by 2022, growing at a CAGR of 10.8% during the forecast period. The netupitant“palonosetron FDC is an oral therapy that targets two critical pathways associated with acute and delayed CINV by blockage of P/NK1 receptors.
Global pharmaceuticals packaging market is expected to reach $104,882 million by 2022 from $68,749 million in 2015, growing at a CAGR of 6.27% from 2016 to 2022. This market is expected to witness notable growth in the coming years, owing ...
IVIG market (Intravenous Immunoglobulin Market) was valued at $7,861 million, and is expected to reach $12,632 million by 2022, supported by a CAGR of 7.1%. Immunoglobulins (IGs) are glycoproteins produced in the blood plasma in response to the antigens, which are foreign to the host system.
Asthma and COPD (Chronic Obstructive Pulmonary Disease) are chronic diseases characterized by airway obstruction in the lungs causing respiratory infection and fatigue. COPD is characterized by yellow phlegm in the cough and episodes of cough and wheezing at night are ...
The global regenerative medicines market is projected to reach $ 30,237 million by 2022. Regenerative medicines have the ability to repair, replace, and regenerate tissues and organs affected due to injury, disease, or natural ageing process. These medicines are capable ...
Global Liver Disease Treatment Market is expected to garner $19,536 million by 2022, registering a CAGR of 11.72% ...
Global Nuclear Medicine Market is expected to garner $8,207.5 million by 2022. The market is currently in its growth stage driven by increasing number of cancer cases and rising awareness about nuclear medicine. Radiopharmaceuticals are pharmaceutical formulations comprising radioactive isotopes ...
Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness.
Analgesics, also known as painkillers, are used to treat and reduce pain in the body. Typically, they are used when the pain is severe and becomes unbearable for the patient. Non-opioids, opioids, and compound analgesics (a combination of both opioids and non-opioids) are the major topical analgesic products used globally.
Pharmaceutical excipients are inert substances, other than the pharmacologically active drug, which are included in the manufacturing process or are present in the pharmaceutical product dosage form. Excipients are widely used in drug formulation to provide long-term stability, add bulkiness ...
LAMEA Oncology/Anti-cancer Drugs Market is expected to reach $17,072.2 million by 2021, registering a CAGR of 8.6% during the forecast period 2015 - 2021. Oncology drugs are used for the treatment or management of the various cancer types. It eventually ...
Biosimilars or follow-on-biologics are highly similar versions of reference biologics derived from living organisms such as plants and animals. The development of biosimilars and validation with reference biologics play a significant role in the commercialization of biosimilars. Economic pricing of ...
Anti-Inflammatory Therapeutics Market is expected to garner $106.1 billion by 2020, registering a CAGR of 5.9% during the forecast period 2015-2020. Inflammation is triggered by the defense system of the body in response to harmful stimuli, damaged cells, irritants and ...
Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs ...
Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumor cell specific genes. Immunotherapies/ biologics are emerging as potential therapies to find the permanent cure for various cancer types. ...
Global Erythropoietin Drugs Market is expected to garner $11.9 billion by 2020, registering CAGR of 9.7% during the forecast period 2014 - 2020. Erythropoietin is a glycoprotein hormone synthesized in the bone marrow that controls and regulates the mechanism of ...
Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF), results from Ebola virus and three other closely related viruses in the genes (group of related viruses) of ebola virus. Initial symptoms of this disease include sore throat, headaches, ...
Nonalcoholic Steatohepatitis (NASH) also known as silent disease is a type of fatty liver disease, which mainly affects people with diabetes and obesity. Symptoms of NASH are found among all demographics (from children to adults); however, they are more prevalent in younger people. Corner stage of cirrhosis is a form of NASH that can be reversed with proper medication.
Global Biosimilars/follow-on-biologics Market was valued at $2,027.0 million in 2014 and is expected to reach $35,032.5 million by 2020, supported by a CAGR of 60.8% during the forecast period 2015 to 2020. Biosimilars or follow-on-biologics are the copied and licensed ...
Page 1 of 7
To ensure high level data integrity, accurate analysis and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
